Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
121,963,764
-
Shares change
-
+6,489,409
-
Total reported value, excl. options
-
$514,346,608
-
Value change
-
+$45,998,596
-
Put/Call ratio
-
47%
-
Number of buys
-
89
-
Number of sells
-
-58
-
Price
-
$4.22
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2022
202 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q3 2022.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121,963,764 shares
of 183,255,226 outstanding shares and own 67% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (11,883,125 shares), BlackRock Inc. (9,258,303 shares), STATE STREET CORP (8,838,706 shares), VANGUARD GROUP INC (8,752,841 shares), Deep Track Capital, LP (8,548,387 shares), BAKER BROS. ADVISORS LP (8,131,678 shares), TANG CAPITAL MANAGEMENT LLC (6,840,000 shares), JPMORGAN CHASE & CO (6,694,598 shares), GREAT POINT PARTNERS LLC (5,645,161 shares), and ArrowMark Colorado Holdings LLC (5,601,107 shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.